Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Kate Stumpo

1PUBLICATIONS
8CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Apr 25, 2020
Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma.

Leo I Gordon, Jason B Kaplan, Rakesh Popat

Pageof 1

Frequent Collaborators

1 joint publications

Leo I Gordon

1 joint publications

Silvia Ferrari

1 joint publications

Giuseppe Gritti

1 joint publications

Dima El-Sharkawi

1 joint publications

Ian Chau

1 joint publications

Jaime Pérez de Oteyza

1 joint publications

Cecilia Carpio

1 joint publications

Francesc Bosch

Frequent Collaborators

1 joint publications

Leo I Gordon

1 joint publications

Silvia Ferrari

1 joint publications

Giuseppe Gritti

1 joint publications

Dima El-Sharkawi

Top Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on : Oct 16, 2018

15.3K
See more related videos

Top Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on : Oct 16, 2018

15.3K
See more related videos